Loading...
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential
Autosomal dominant polycystic kidney disease is characterized by progressive development and enlargement of kidney cysts, leading to ESKD. Because the kidneys are under high metabolic demand, it is not surprising that mounting evidence suggests that a metabolic defect exists in in vitro and animal m...
Saved in:
| Published in: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Nephrology
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133124/ https://ncbi.nlm.nih.gov/pubmed/32086281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.13291019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|